Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001493152-24-050290
Filing Date
2024-12-16
Accepted
2024-12-16 17:30:32
Documents
14

Document Format Files

Seq Description Document Type Size
1 form424b5.htm 424B5 1215846
2 form424b5_001.jpg GRAPHIC 13933
3 form424b5_002.jpg GRAPHIC 107690
4 form424b5_003.jpg GRAPHIC 181297
5 form424b5_004.jpg GRAPHIC 121795
6 form424b5_005.jpg GRAPHIC 160857
7 form424b5_007.jpg GRAPHIC 56332
8 form424b5_008.jpg GRAPHIC 155385
9 form424b5_009.jpg GRAPHIC 100336
10 form424b5_010.jpg GRAPHIC 168832
11 form424b5_011.jpg GRAPHIC 99099
12 form424b5_012.jpg GRAPHIC 87148
13 form424b5_013.jpg GRAPHIC 97217
14 form424b5_014.jpg GRAPHIC 115636
  Complete submission text file 0001493152-24-050290.txt   3237222
Mailing Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR
Business Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR 01414337557
TC BioPharm (Holdings) plc (Filer) CIK: 0001872812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-283507 | Film No.: 241552954
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)